{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:24:20Z","timestamp":1766082260626,"version":"3.48.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijcard.2025.134009","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T07:58:27Z","timestamp":1762415907000},"page":"134009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospective safety assessment of the acute vasoreactivity test using an inhaled nitric oxide delivery system in pulmonary hypertension"],"prefix":"10.1016","volume":"444","author":[{"given":"Shun","family":"Minatsuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kiriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2025.134009_bb0005","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0010","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0735-1097(00)00994-3","article-title":"Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology","volume":"36","author":"Krasuski","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134009_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.122.063821","article-title":"Positive vasoreactivity testing in pulmonary arterial hypertension: therapeutic consequences, treatment patterns, and outcomes in the modern management era","volume":"149","author":"Gerhardt","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0025","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.134009_bb0030","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"J.53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir."},{"key":"10.1016\/j.ijcard.2025.134009_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10047-013-0706-4","article-title":"Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation","volume":"16","author":"Imamura","year":"2013","journal-title":"J. Artif. Organs"},{"key":"10.1016\/j.ijcard.2025.134009_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/crj.13173","article-title":"Sex differences of hemodynamics during acute vasoreactivity testing to predict the outcomes of chronic thromboembolic pulmonary hypertension","volume":"J.14","author":"Yang","year":"2020","journal-title":"Clin. Res."},{"key":"10.1016\/j.ijcard.2025.134009_bb0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.108.794610","article-title":"Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study","volume":"119","author":"Skoro-Sajer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0735-1097(99)00494-5","article-title":"A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group","volume":"35","author":"Hoeper","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.134009_bb0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0195-668X(02)00302-0","article-title":"Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation","volume":"J.24","author":"Opitz","year":"2003","journal-title":"Eur. Heart"},{"key":"10.1016\/j.ijcard.2025.134009_bb0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/ajrccm.151.2.7842196","article-title":"Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin","volume":"151","author":"Sitbon","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.jvca.2007.10.015","article-title":"Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial","volume":"22","author":"Winterhalter","year":"2008","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2025.134009_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019857533","article-title":"EXPRESS: acute vasoreactivity testing in pediatric idiopathic pulmonary arterial hypertension: an international survey on current practice","volume":"9","author":"Caicedo","year":"2019","journal-title":"Pulm Circ."},{"key":"10.1016\/j.ijcard.2025.134009_bb0075","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","article-title":"Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017)","volume":"J.83","author":"Fukuda","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11748-023-01971-2","article-title":"Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan","volume":"72","author":"Matsugi","year":"2024","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2025.134009_bb0085","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","article-title":"Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report","volume":"146","author":"Taichman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2025.134009_bb0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/680355","article-title":"Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension","volume":"5","author":"Milger","year":"2015","journal-title":"Pulm Circ."},{"key":"10.1016\/j.ijcard.2025.134009_bb0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIR.0b013e31829b5b44","article-title":"Exercise standards for testing and training: a scientific statement from the American Heart Association","volume":"128","author":"Fletcher","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","article-title":"Clinician\u2019s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association","volume":"122","author":"Balady","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.134009_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.md.0000141096.00377.3f","article-title":"Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals","volume":"83","author":"Ash-Bernal","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2025.134009_bb0115","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.amjmed.2015.04.031","article-title":"Methemoglobinemia: a diagnosis not to be missed","volume":"128","author":"Lata","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.134009_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/59.1.5","article-title":"The toxicology of inhaled nitric oxide","volume":"59","author":"Weinberger","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ijcard.2025.134009_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09031936.98.12020265","article-title":"Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension","volume":"J.12","author":"Sitbon","year":"1998","journal-title":"Eur. Respir."},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2025.134009_bb0140","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1513\/AnnalsATS.201509-623AS","article-title":"Diagnostic evaluation of chronic thromboembolic pulmonary hypertension","volume":"13","author":"Gopalan","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.ijcard.2025.134009_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/acs-2021-pte-10","article-title":"Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology","volume":"11","author":"Simonneau","year":"2022","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2025.134009_bb0150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.00169113","article-title":"Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature","volume":"J.44","author":"Dorfm\u00fcller","year":"2014","journal-title":"Eur. Respir."},{"key":"10.1016\/j.ijcard.2025.134009_bb0155","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"J.53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir."},{"key":"10.1016\/j.ijcard.2025.134009_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.111.051540","article-title":"Pulmonary capillary wedge pressure augments right ventricular pulsatile loading","volume":"125","author":"Tedford","year":"2012","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325010526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325010526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:19:41Z","timestamp":1766081981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325010526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0167527325010526"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134009","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective safety assessment of the acute vasoreactivity test using an inhaled nitric oxide delivery system in pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134009"}}